These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 19024623)

  • 1. [A reply on subsidizing of antihypertensive agents: the problem is exceptional undertreatment of hypertension].
    Willenheimer R; Nyström F; Berggren B; Lindström T; Cizinsky S; Weiss L
    Lakartidningen; 2008 Oct 22-28; 105(43):3055-6. PubMed ID: 19024623
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertension treatment and control in Sub-saharan Africa. Figure of $1800 per life saved seems optimistic.
    Burdon J
    BMJ; 1998 Jul; 317(7150):76; author reply 77. PubMed ID: 9651283
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension control: improved, but not enough!
    Alderman MH
    Am J Hypertens; 2007 Apr; 20(4):347. PubMed ID: 17386338
    [No Abstract]   [Full Text] [Related]  

  • 4. [The pharmaco-economics of the treatment of arterial hypertension: data and controversies].
    Rorive G; Delporte JP
    Bull Mem Acad R Med Belg; 1998; 153(7-9):317-21; discussion 322-4. PubMed ID: 10100395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in medical expenditure according to drug prices.
    Ueshima H
    Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacotherapy of hypertension. How much can safely be saved?].
    Anlauf M
    MMW Fortschr Med; 2004 Apr; 146(15):57-8. PubMed ID: 15373022
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hypertension in Sweden: treatment of patients with hypertension costs more than a billion crowns per year].
    Johannesson M; Borgqvist L; Jönsson B; Råstam L
    Lakartidningen; 1991 Mar; 88(12):1103-6. PubMed ID: 2016946
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fully possible to reduce the costs of hypertension treatment].
    Wettermark B; Angman A; Hjemdahl P
    Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of combination therapy in achieving blood pressure control.
    Neutel JM
    Am J Manag Care; 1999 Jun; 5(7 Suppl):S463-8. PubMed ID: 10538855
    [No Abstract]   [Full Text] [Related]  

  • 10. [No value for money with certain antihypertensive agents].
    Edling A; Löfmark R; Vinge E; Carlsson P; André M; Melltorp G; Edhag O; Dahlqvist R; Andersson I; Magnusson D
    Lakartidningen; 2008 Nov 26-Dec 9; 105(48-49):3565. PubMed ID: 19133587
    [No Abstract]   [Full Text] [Related]  

  • 11. Angiotensin receptor blockers: impact on costs of care.
    Am J Manag Care; 2005 Nov; 11(13 Suppl):S400-3. PubMed ID: 16300456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health economic issues and the future treatment and management of hypertension.
    Giles TD
    AAPPO J; 1994; 4(4):27-8, 30, 33-5. PubMed ID: 10150589
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comment on IOWiG report plan. A medical decision may not be replaced].
    Vorstand der Deutschen Hochdruckliga E.V
    MMW Fortschr Med; 2006 May; 148(19):42. PubMed ID: 16736705
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hypertension at a health center. 1: The drugs prescribed for men are much more expensive than the ones prescribed for women].
    Johannesson M; Borgquist L; Elenstål A; Jönsson B; Tilling B
    Lakartidningen; 1991 Mar; 88(12):1096-8. PubMed ID: 2016944
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical economics of hypertension therapy].
    Yamazaki T
    Nihon Rinsho; 2008 Aug; 66(8):1601-4. PubMed ID: 18700564
    [No Abstract]   [Full Text] [Related]  

  • 16. First-line drugs for hypertension.
    Spence JD
    CMAJ; 2001 Jan; 164(2):176-8. PubMed ID: 11332306
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug committees welcome the SBU hypertension report. A number of patients can be offered cost-effective, evidence-based therapy].
    Ohlsson O
    Lakartidningen; 2004 Dec; 101(49):3984-5. PubMed ID: 15633336
    [No Abstract]   [Full Text] [Related]  

  • 18. [Real and assumed potential savings in antihypertensive treatment. Right out of the magician's hat].
    Anlauf M; Hense HW
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1557-9. PubMed ID: 12854069
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost of hypertension treatment and the price of health.
    Menard J; Cornu P; Day M
    J Hum Hypertens; 1992 Dec; 6(6):447-58. PubMed ID: 1296008
    [No Abstract]   [Full Text] [Related]  

  • 20. [Health care too costly? Saving more than 10 million euros in 2 months!].
    Rappert B
    MMW Fortschr Med; 2003 Nov; 145(47):65. PubMed ID: 14725043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.